Cargando…

Estrogen Receptor and Claudin-6 Might Play Vital Roles for Long-Term Prognosis in Patients With Luminal A Breast Cancer Who Underwent Neoadjuvant Chemotherapy

PURPOSE: It is well-known that the pathological complete response (pCR) rate in patients with luminal A cancer (LAC) is lower than those of other subtypes of breast cancer. The phenotype of cancer often alters after neoadjuvant chemotherapy (NAC) which may be related to hypoxia, and the latter might...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yushi, Kang, Ye, Li, Jianyi, Zhang, Yang, Jia, Shi, Sun, Qiang, Ma, Yan, Zhang, Jing, Wang, Zhenrong, Cao, Yanan, Shen, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280129/ https://www.ncbi.nlm.nih.gov/pubmed/35847894 http://dx.doi.org/10.3389/fonc.2022.630065

Ejemplares similares

Association of PTP1B with Outcomes of Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy
por: Rivera Franco, Monica M., et al.
Publicado: (2016)

Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy
por: Jiang, Cong, et al.
Publicado: (2022)

The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy
por: Lee, Janghee, et al.
Publicado: (2021)

Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers
por: Mudduwa, Lakmini, et al.
Publicado: (2017)

Feasibility research of enhanced recovery after surgery implemented in esophageal cancer patients who underwent neoadjuvant chemotherapy
por: Tang, Zhanpeng, et al.
Publicado: (2022)

Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
por: Lee, So Heun, et al.
Publicado: (2023)

Tumor infiltrating neutrophil might play a major role in predicting the clinical outcome of breast cancer patients treated with neoadjuvant chemotherapy
por: Geng, Sheng-Kai, et al.
Publicado: (2021)

Estrogen response in luminal breast cancer
por: Rangel, Leticia B. A., et al.
Publicado: (2013)

Post-therapy pathologic tumor volume predicts survival in gastric cancer patients who underwent neoadjuvant chemotherapy and gastrectomy
por: Tang, Xiaolong, et al.
Publicado: (2019)

Neoadjuvant therapy does not adversely affect the short-term outcome of critically ill cancer patients who underwent surgery
por: Xing, Xue-Zhong, et al.
Publicado: (2020)

Na(+)-Coupled Nutrient Cotransport Induced Luminal Negative Potential and Claudin-15 Play an Important Role in Paracellular Na(+) Recycling in Mouse Small Intestine
por: Nakayama, Michiko, et al.
Publicado: (2020)

Inhibition of proliferation and migration of luminal and claudin-low breast cancer cells by PDGFR inhibitors
por: Stalker, Leanne, et al.
Publicado: (2014)

ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer
por: Gong, Yajie, et al.
Publicado: (2020)

Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer
por: Zhang, Zhuo, et al.
Publicado: (2021)

Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?
por: Alan, Ozkan, et al.
Publicado: (2020)

Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells
por: Rädler, Patrick D., et al.
Publicado: (2021)

Effect of neoadjuvant chemotherapy on survival in patients with T1 high-grade non-muscle-invasive bladder cancer who underwent radical cystectomy
por: Huang, Long, et al.
Publicado: (2023)

Claudins play a role in normal and tumor cell motility
por: Webb, Patricia G, et al.
Publicado: (2013)

Role of Estrogen Receptor-α in the Regulation of Claudin-6 Expression in Breast Cancer Cells
por: Yafang, Liu, et al.
Publicado: (2011)

Hypertonic saline for prevention of delirium in geriatric patients who underwent hip surgery
por: Xin, Xi, et al.
Publicado: (2017)

Prognosis of post-neoadjuvant therapy patients who underwent immediate breast reconstruction: a SEER-based, propensity-matched study
por: Pan, Jiahao, et al.
Publicado: (2023)

Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype(−) Breast Cancer
por: Kim, Hyung Suk, et al.
Publicado: (2019)

The Neutrophil to Lymphocyte Ratio Predicts the Response to Neoadjuvant Chemotherapy in Luminal B Breast Cancer
por: Rivas, Mauricio, et al.
Publicado: (2019)

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
por: Thompson, Kevin J, et al.
Publicado: (2022)

Claudin18.who? Examining biomarker overlap and outcomes in claudin18.2-positive gastroesophageal adenocarcinomas
por: Klempner, S.J., et al.
Publicado: (2023)

Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial
por: Wang, Hao, et al.
Publicado: (2021)

Collagenous Colitis in a Patient With Gastric Cancer Who Underwent Chemotherapy
por: Iwamuro, Masaya, et al.
Publicado: (2023)

Prognostic factors in patients with thymoma who underwent surgery
por: Jiang, Yu-Gang, et al.
Publicado: (2023)

Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression
por: Chen, F, et al.
Publicado: (2014)

Abnormally increased DNA methylation in chorionic tissue might play an important role in development of ectopic pregnancy
por: Cai, Wen, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial
por: Dieci, Maria Vittoria, et al.
Publicado: (2022)

The role and mechanism of claudins in cancer
por: Wang, De-Wen, et al.
Publicado: (2022)

Neutrophil to Lymphocyte Ratio: A Predictive Marker for Treatment Outcomes in Patients With Rectal Cancer Who Underwent Neoadjuvant Chemoradiation Followed by Surgery
por: Jeon, Byong Ho, et al.
Publicado: (2019)

The claudins
por: Lal-Nag, Madhu, et al.
Publicado: (2009)

Claudin and pancreatic cancer
por: Wang, Chen, et al.
Publicado: (2023)

Methylation of the Claudin 1 Promoter Is Associated with Loss of Expression in Estrogen Receptor Positive Breast Cancer
por: Di Cello, Francescopaolo, et al.
Publicado: (2013)

Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer
por: Kumar, Sushil, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast Cancer
por: Zhu, Xudong, et al.
Publicado: (2019)

Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy
por: Pfefferle, Adam D., et al.
Publicado: (2015)

DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer
por: Sigin, Vladimir O., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_21t4b02btirdflim65km8rmo62